速度试验的专业知识，以促进价值的见解。betway必威怎么提款
With broadening populations, expanding treatment options, and new digital support tools, understanding the science and the value in treating diabetes is becoming even more critical.
对糖尿病的端到端支持
IQVIA汇集了整个产品生命周期中糖尿病的卓越专业知识，以帮助您提高开发计划的效率并最大程度地提高新疗法的价值。
- 为您的开发计划提供动力with real world data and predictive analytics to increase trial efficiency and bring differentiated diabetes therapies to patients, faster
- Support your clinical and sales teams具有无与伦比的糖尿病来源富含EMR和纵向处方数据
- Couple real-world data with our Core Diabetes Model, the most widely used economic model in the healthcare industry, to accurately predict health outcomes and costs in type 1 and type 2 diabetes
- 改善商业成果通过使用现实世界数据来影响销售部队的效率，定位，呼叫活动和品牌绩效
案例研究：在糖尿病试验中实现雄心勃勃的目标
In a recent Phase III Type I diabetes trial, IQVIA faced aggressive timelines to meet a submission deadline.
Through the power of the IQVIA Connected Intelligence™, we were able to accelerate both site ID and patient recruitment1 to help our customer meet the critical regulatory filing dates.
1Comparison based on previous studies conducted by IQVIA in the same indication and geographies.
Leading the Way in Continuous Glucose Monitoring
HbA1c measures alone are no longer enough in diabetes drug development. Continuous Glucose Monitoring (CGM) is increasingly becoming a part of clinical research as well as routine patient management, as it helps improve medication compliance and enforce lifestyle interventions and overall protocol adherence.
iqvia’s CGM solution has been recognized as a valid research tool. It is one of the few CGM solutions that are compliant with 21 CFR Part 11. By integrating devices with our automated data capture and advanced analytics, we’re able to deliver more robust data, with less delay – so you can reach better decisions, faster.
Producers, Supply and Cost
